Tetraphase Pharmaceu
(TTPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,124 | -70,085 | -58,713 | -42,409 | -19,488 |
| Depreciation Amortization | 112 | 633 | 520 | 405 | 201 |
| Accounts receivable | -203 | 772 | 565 | 546 | 457 |
| Accounts payable and accrued liabilities | -452 | -781 | -1,458 | -1,131 | -518 |
| Other Working Capital | 516 | -3,094 | -2,665 | 26 | -3,778 |
| Other Operating Activity | 996 | 8,885 | 9,020 | 5,808 | 3,007 |
| Operating Cash Flow | $-11,155 | $-63,670 | $-52,731 | $-36,755 | $-20,119 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 130 | 478 | -96 | -106 | -98 |
| Investing Cash Flow | $130 | $478 | $-96 | $-106 | $-98 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -30,480 | -30,480 | N/A | N/A |
| Common Stock Issued | 15,932 | 7,135 | 39 | 39 | N/A |
| Financing Cash Flow | $15,932 | $-23,345 | $-30,441 | $39 | $N/A |
| Beginning Cash Position | 21,938 | 108,475 | 108,475 | 108,475 | 108,475 |
| End Cash Position | 26,845 | 21,938 | 25,207 | 71,653 | 88,258 |
| Net Cash Flow | $4,907 | $-86,537 | $-83,268 | $-36,822 | $-20,217 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,155 | -63,670 | -52,731 | -36,755 | -20,119 |
| Capital Expenditure | 0 | -108 | -108 | -106 | -98 |
| Free Cash Flow | -11,155 | -63,778 | -52,839 | -36,861 | -20,217 |